Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -149

Accepted - Volume 3

Comment Record
Commentor Dr. Lee Echelbarger Date/Time 2002-11-04 21:28:41
Organization Back In Line Chiropractic
Category Health Professional

Comments for FDA General
Questions
1. General Comments i strongly disapprove of the study as it puts children in a risk category for more than just small pox, but a variety of immune diseases that have been documented in various journals as well as suppression of their normally developing immune systems.




EC -149